One of the key elements of a Chapter 11 plan that bankruptcy courts must tackle is the extent of the plan’s releases, including whether a requirement that parties must affirmatively “opt-out” of a plan’s releases sufficiently manifests consent to the releases for those that do not opt-out. The U.S. Supreme Court’s 2024 decision in Harrington v. Purdue Pharma sparked nationwide debate over how consent to third-party releases is addressed in Chapter 11 bankruptcy plans.